US Pharma MarketingFive considerations for adopting AI in clinical study build workflows
Five considerations for adopting AI in clinical study build workflows is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
AI can accelerate study-build foundations, but only when teams combine targeted automation with standards, traceability and control.
Source: Pharmaceutical Technology